Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
企業コードALUR_t
会社名Allurion Technologies Inc
上場日Mar 29, 2021
設立日2023
最高経営責任者「CEO」Dr. Shantanu Gaur, M.D.
従業員数- -
証券種類- -
決算期末- -
本社所在地11 Huron Dr Ste 200
都市NATICK
証券取引所- -
国United States of America
郵便番号01760
電話番号15086474000
ウェブサイトhttps://www.allurion.com/en
企業コードALUR_t
上場日Mar 29, 2021
設立日2023
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし